An alternative improved synthesis of (-) -norferruginine, a potent nAChR agonist
Wegge, T.; Schwarz, S.; Seitz, G.
Die Pharmazie 55(10): 779-780
2000
ISSN/ISBN: 0031-7144 PMID: 11082844 Document Number: 520760
Document emailed within 1 workday
Related Documents
Durant, G.J.; Duncan, W.A.; Ganellin, C.R.; Parsons, M.E.; Blakemore, R.C.; Rasmussen, A.C. 1978: Impromidine (SK&F 92676) is a very potent and specific agonist for histamine H2 receptors Nature 276(5686): 403-405Brennan, M.J.; Cantrill, R.C. 1979: Delta-aminolaevulinic acid is a potent agonist for GABA autoreceptors Nature 280(5722): 514-515
Nathanson, J.A.; Hunnicutt, E.J. 1981: N-demethylchlordimeform: a potent partial agonist of octopamine-sensitive adenylate cyclase Molecular Pharmacology 20(1): 68-75
Satoh, M.; Sakai, T.; Sano, I.; Fujikura, K.; Koyama, H.; Ohshima, K.; Itoh, Z.; Omura, S. 1994: EM574, an erythromycin derivative, is a potent motilin receptor agonist in human gastric antrum Journal of Pharmacology and Experimental Therapeutics 271(1): 574-579
Kem, W.R.; Mahnir, V.M.; Papke, R.L.; Lingle, C.J. 1997: Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors Journal of Pharmacology and Experimental Therapeutics 283(3): 979-992
Burris, K.D.; Breeding, M.; Sanders-Bush, E. 1991: (+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonist Journal of Pharmacology and Experimental Therapeutics 258(3): 891-896
Koek, W.; Patoiseau, J.F.; Assié, M.B.; Cosi, C.; Kleven, M.S.; Dupont-Passelaigue, E.; Carilla-Durand, E.; Palmier, C.; Valentin, J.P.; John, G.; Pauwels, P.J.; Tarayre, J.P.; Colpaert, F.C. 1998: F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential Journal of Pharmacology and Experimental Therapeutics 287(1): 266-283
Kunimoto, D.Y.; Nordan, R.P.; Strober, W. 1989: IL-6 is a potent cofactor of IL-1 in IgM synthesis and of IL-5 in IgA synthesis Journal of Immunology 143(7): 2230-2235
Curran, D.P. 1998: Fluorous synthesis: an alternative to organic synthesis and solid phase synthesis for the preparation of small organic molecules Cancer Journal from Scientific American 4(Suppl 1): S73-S76
Elliott, C.T.; McEvoy, J.D.; McCaughey, W.J.; Crooks, S.R.; Hewitt, S.A. 1993: Improved detection of the beta-agonist clenbuterol by analysis of retina extracts Veterinary Record 132(12): 301-302
2002: Dopamine agonist is effective in Parkinson disease not only against tremor. Depression is also improved MMW Fortschritte der Medizin Suppl. 2: 88
Rodríguez de Fonseca, F.; Rubio, P.; Menzaghi, F.; Merlo-Pich, E.; Rivier, J.; Koob, G.F.; Navarro, M. 1996: Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats Journal of Pharmacology and Experimental Therapeutics 276(1): 56-64
Donetti, A.; Mantegani, A.; Marazzi-Uberti, E. 1970: Synthesis and aanalgesic activity of some compounds related to propoxyphene. II. Selective ring opening of an asymmetric epoxide with isobutenyllithium: an alternative synthesis of gamma-substituted allyl carbinols Il Farmaco; Edizione Scientifica 25(7): 500-508
Widakowich, J. 1987: Alternative treatment resulting in improved vision? Lakartidningen 84(51): 4346
Pandeya, S.; Agarwal, A.K.; Singh, A.; Stables, J.P. 2003: Design and synthesis of semicarbazones and their bio-isosteric analogues as potent anticonvulsants: the role of hydrogen bonding Acta Pharmaceutica 53(1): 15-24
Baston, E.; Klein, C.D.; Grimminger, W.; Hebecker, N.; Hartmann, R.W. 2001: Synthesis, evaluation and QSAR studies of highly potent aromatase inhibitors of the piperidinedione type Anti-Cancer Drug Design 16(1): 37-47
Malhotra, M.; Sharma, R.; Sanduja, M.; Kumar, R.; Jain, J.; Deep, A. 2012: Synthesis, characterization and evaluation of mannich bases as potent antifungal and hydrogen peroxide scavenging agents Acta Poloniae Pharmaceutica 69(2): 355-361
Dal Piaz, V.; Ciciani, G.; Giovannoni, M.P. 1997: Synthesis of 4,5-functionalized-2-methyl-6-(substituted aryl)-3 (2H)-pyridazinones: a new group of potent platelet aggregation inhibitors Farmaco 52(3): 173-178
Malhotra, M.; Hans, P.; Sharma, S.; Deep, A.; Phogat, P. 2012: Synthesis and characterization of (Z)-N-(1-[2-{3-[(dimethylamino)methyl)]-2-methoxyphenyl}-5-(pyridin-4-yl)-1,3,4-oxadiazol-3(2H)-yl]ethylidene) benzenamine derivatives as potent antifungal agents Acta Poloniae Pharmaceutica 69(3): 433-438
Sugiyama, T.; Hashizume, T. 1980: An alternative synthesis of deuterated cytokinins Nucleic Acids Symposium Series 8: S27-S30